ACA-Required Cancer Screenings
| Screening | Recommended Population | ACA Coverage |
|---|---|---|
| Colorectal cancer screening | Adults 45–75 | $0 cost-sharing required |
| Breast cancer mammography | Women 40–74 (annual) | $0 cost-sharing required |
| Cervical cancer (Pap smear) | Women 21–65 | $0 cost-sharing required |
| Lung cancer (low-dose CT) | Adults 50–80 with smoking history | $0 cost-sharing required |
| Skin cancer counseling | Adults with fair skin | $0 cost-sharing required |
Improving Screening Rates
Despite ACA requirements for $0 cost-sharing, cancer screening rates remain below recommended levels. Colorectal cancer screening rates are 68%; breast cancer screening rates are 72%; cervical cancer screening rates are 75%. Employer-sponsored screening campaigns — reminders, incentives, and on-site screening events — can significantly improve these rates.
Genetic Testing
IQ Insight
Genetic testing for hereditary cancer risk — BRCA1/2 for breast and ovarian cancer, Lynch syndrome for colorectal cancer — is an emerging area of employer benefits. Employees who test positive for hereditary cancer risk can take preventive action — increased screening, prophylactic surgery, or chemoprevention — that dramatically reduces their cancer risk. Covering genetic testing for hereditary cancer risk is a high-value preventive benefit.